|
1
|
Rönnblom L and Pascual V: The innate
immune system in SLE: Type I interferons and dendritic cells.
Lupus. 17:394–399. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Coluccia AM, Cirulli T, Neri P, Mangieri
D, Colanardi MC, Gnoni A, Di Renzo N, Dammacco F, Tassone P,
Ribatti D, et al: Validation of PDGFRbeta and c-Src tyrosine
kinases as tumor/vessel targets in patients with multiple myeloma:
Preclinical efficacy of the novel, orally available inhibitor
dasatinib. Blood. 112:1346–1356. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Egner W: The use of laboratory tests in
the diagnosis of SLE. J Clin Pathol. 53:424–432. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Su DL, Wang HJ, Ji XH, Li YY, Xuan HB,
Heng C and Li YF: Mycophenolic acid inhibits SLE-associated
cytokine expression and promotes apoptosis of peripheral blood
mononuclear cells from patients with systemic lupus erythematosus.
Acta Pharmacol Sin. 27:1051–1057. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Mackay M, Stanevsky A, Wang T, Aranow C,
Li M, Koenig S, Ravetch JV and Diamond B: Selective dysregulation
of the FcgammaIIB receptor on memory B cells in SLE. J Exp Med.
203:2157–2164. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhao P, Xu L, Wang P, Liang X, Qi J, Liu
P, Guo C, Zhang L, Ma C and Gao L: Increased expression of human
T-cell immunoglobulin- and mucin-domain-containing molecule-4 in
peripheral blood mononuclear cells from patients with system lupus
erythematosus. Cell Mol Immunol. 7:152–156. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yu SL, Wong CK, Wong PTY, Chen DP, Szeto
CC, Li EK and Tam LS: Down-regulated NOD2 by immunosuppressants in
peripheral blood cells in patients with SLE reduces the muramyl
dipeptide-induced IL-10 production. PLoS One. 6:e238552011.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Muratori P, Muratori L, Ferrari R, Cassani
F, Bianchi G, Lenzi M, Rodrigo L, Linares A, Fuentes D and Bianchi
FB: Characterization and clinical impact of antinuclear antibodies
in primary biliary cirrhosis. Am J Gastroenterol. 98:431–437. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Xu XF, Zhang J, Cui L, Wang YH, Yue Y, Chi
L, Bai J, Li HM and Lu XX: The value of different antibodies
detection in diagnosis of rheumatism with uveitis. Zhonghua Yi Xue
Za Zhi. 97:285–290. 2017.(In Chinese). PubMed/NCBI
|
|
10
|
Song XY, Huang H, Liu YZ, Zhao YY, Li S
and Xu ZJ: Coexistence of sarcoidosis and primary Sjögren syndrome:
A clinical analysis and literature review. Zhonghua Nei Ke Za Zhi.
56:375–377. 2017.(In Chinese). PubMed/NCBI
|
|
11
|
Buhl A, Metzger JH, Heegaard NH, von
Landenberg P, Fleck M and Luppa PB: Novel biosensor-based analytic
device for the detection of anti-double-stranded DNA antibodies.
Clin Chem. 53:334–341. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Calano SJ, Shih PA, Liu CC, Kao AH,
Navratil JS, Manzi S and Ahearn JM: Cell-bound complement
activation products (CB-CAPs) as a source of lupus biomarkers. Adv
Exp Med Biol. 586:381–390. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hochberg MC: Updating the American College
of Rheumatology revised criteria for the classification of systemic
lupus erythematosus. Arthritis Rheum. 40:17251997. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Liu Y, Jing H, Wang J, Zhang R, Zhang Y,
Zhang Y, Xu Q, Yu X and Xue C: Micronutrients decrease incidence of
common infections in type 2 diabetic outpatients. Asia Pac J Clin
Nutr. 20:375–382. 2011.PubMed/NCBI
|
|
15
|
Salaman MR and Isenberg DA: The
immunological personality of close relatives of SLE patients.
Lupus. 26:1513–1516. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Liu CC, Manzi S, Kao AH, Navratil JS and
Ahearn JM: Cell-bound complement biomarkers for SLE: From benchtop
to bedside. Rheum Dis Clin North Am. 36:161–172. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kumar Y and Bhatia A: Detection of
antinuclear antibodies in SLE. Methods Mol Biol. 1134:37–45. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kasitanon N, Magder LS and Petri M:
Predictors of survival in systemic lupus erythematosus. Medicine
(Baltimore). 85:147–156. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Li LH, Pan HF, Li WX, Li XP, Xu JH and Ye
DQ: Study on clinical features and complications with systemic
lupus erythematosus (SLE) activity in Chinese Han population. Clin
Rheumatol. 28:1301–1307. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Roggenbuck D, Reinhold D, Hiemann R,
Anderer U and Conrad K: Standardized detection of anti-ds DNA
antibodies by indirect immunofluorescence - a new age for
confirmatory tests in SLE diagnostics. Clin Chim Acta.
412:2011–2012. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Waris G and Alam K: Immunogenicity of
superoxide radical modified-DNA: Studies on induced antibodies and
SLE anti-DNA autoantibodies. Life Sci. 75:2633–2642. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Liu H, Yang LH, Yin G and Xie QB:
Correlation of thyroid autoantibodies, system lupus erythematosus
immunologic indicators and disease activity in SLE with HT. Sichuan
Da Xue Xue Bao Yi Xue Ban. 49:179–182. 2018.(In Chinese).
PubMed/NCBI
|
